Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-05

FDA Approved: SUMATRIPTAN — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Sumatriptan from Cipla USA Inc., supporting marketing of this generic migraine medication. The action pertains t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)